Deog J Kim

Summary

Publications

  1. ncbi Clavulanic acid: a competitive inhibitor of beta-lactamases with novel anxiolytic-like activity and minimal side effects
    Deog J Kim
    Rexahn Pharmaceuticals Inc, Rockville, Maryland 20850, USA
    Pharmacol Biochem Behav 93:112-20. 2009

Detail Information

Publications1

  1. ncbi Clavulanic acid: a competitive inhibitor of beta-lactamases with novel anxiolytic-like activity and minimal side effects
    Deog J Kim
    Rexahn Pharmaceuticals Inc, Rockville, Maryland 20850, USA
    Pharmacol Biochem Behav 93:112-20. 2009
    ..The fact clavulanic acid has anxiolytic activity in the tamarin holds the promise that this drug may be an effective therapeutic for the treatment of anxiety disorders in humans...